As part of its modernization effort, the USP has updated several monographs to include ion chromatography (IC) as an analysis ...

Expanded Coverage Reaches Over 100 Million Covered Lives Nationwide COMMACK, NY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC.

COMMACK, NY - Scienture Holdings, Inc. (NASDAQ:SCNX) announced Tuesday that its Arbli (losartan potassium) Oral Suspension has been added to formularies of key national payors, expanding access to ...

ALBANY, Ore., Nov. 4, 2025 /PRNewswire/ -- Synergy Dental Partners and Oral BioTech are proud to announce a strategic partnership aimed at enhancing oral health care for dental professionals and their ...

The MarketWatch News Department was not involved in the creation of this content. ALBANY, Ore., Nov. 4, 2025 /PRNewswire/ -- Synergy Dental Partners and Oral BioTech are proud to announce a strategic ...

Scienture Holdings, Inc. (NASDAQ:SCNX) announced on Tuesday that Arbli (losartan potassium) Oral Suspension, 10 mg/mL, has been added to the formularies of key national payors, expanding access ...

Company launches multi-channel promotional campaign to drive market adoption U.S. losartan market totals $256M annually with 71M prescriptions, creating a significant opportunity for Arbli ™ as the ...